Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BZAINYSE:CLPRNYSE:FVRNASDAQ:OACC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBZAIBlaize$2.86+1.4%$2.46$1.70▼$19.25$290.81M0.25581,077 shs122,622 shsCLPRClipper Realty$3.72-3.9%$3.89$3.38▼$7.12$60.08M0.99120,136 shs17,534 shsFVRFrontView REIT$12.21-2.2%$11.77$10.61▼$19.76$232.80MN/A258,046 shs47,012 shsOACCOaktree Acquisition Corp. III Life Sciences$10.41-0.3%$10.48$9.95▼$10.85$233.39MN/A111,063 shs171 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBZAIBlaize0.00%+20.00%+10.59%+12.35%+281,999,900.00%CLPRClipper Realty0.00%+3.62%-0.74%+8.26%+9.80%FVRFrontView REIT0.00%+1.25%+7.83%+12.11%+1,247,999,900.00%OACCOaktree Acquisition Corp. III Life Sciences0.00%-0.50%-0.85%+2.76%+1,043,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBZAIBlaizeN/AN/AN/AN/AN/AN/AN/AN/ACLPRClipper Realty0.4743 of 5 stars0.03.01.70.00.01.70.0FVRFrontView REIT1.7805 of 5 stars3.20.02.50.00.60.00.6OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBZAIBlaize 3.00Buy$5.83103.96% UpsideCLPRClipper Realty 0.00N/AN/AN/AFVRFrontView REIT 2.40Hold$16.8037.59% UpsideOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CLPR, BZAI, FVR, and OACC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/1/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.006/17/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$15.00 ➝ $11.006/17/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$14.00 ➝ $12.006/10/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $14.005/15/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.005/6/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$15.004/22/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$3.004/11/2025FVRFrontView REITWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$19.00 ➝ $17.004/8/2025BZAIBlaizeCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$4.50(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBZAIBlaize$1.55M187.62N/AN/A($2.16) per share-1.32CLPRClipper Realty$148.77M0.40$1.79 per share2.08($0.88) per share-4.23FVRFrontView REIT$66.68M3.50$0.49 per share24.78$30.23 per share0.40OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBZAIBlaize-$4.11MN/A0.00∞N/AN/AN/A-21.91%N/ACLPRClipper Realty-$2.50M-$1.02N/A31.00N/A-9.73%N/A-1.16%7/30/2025 (Estimated)FVRFrontView REIT-$22.21MN/A0.0010.26N/AN/AN/AN/A8/13/2025 (Estimated)OACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CLPR, BZAI, FVR, and OACC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BZAIBlaizeN/A-$0.29N/A-$1.61N/AN/A5/12/2025Q1 2025CLPRClipper Realty$0.16$0.19+$0.03$0.19$40.40 million$39.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBZAIBlaizeN/AN/AN/AN/AN/ACLPRClipper Realty$0.3810.22%N/AN/A N/AFVRFrontView REIT$0.867.04%N/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ALatest CLPR, BZAI, FVR, and OACC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/15/2025FVRFrontView REITquarterly$0.21507.4%6/30/20256/30/20257/15/20255/13/2025CLPRClipper Realtyquarterly$0.09509.1%5/27/20255/27/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBZAIBlaizeN/A2.432.22CLPRClipper RealtyN/A0.040.04FVRFrontView REIT0.600.170.17OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBZAIBlaize97.12%CLPRClipper Realty37.57%FVRFrontView REITN/AOACCOaktree Acquisition Corp. III Life SciencesN/AInsider OwnershipCompanyInsider OwnershipBZAIBlaize68.50%CLPRClipper Realty53.01%FVRFrontView REIT4.30%OACCOaktree Acquisition Corp. III Life SciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBZAIBlaizeN/A101.68 million32.03 millionN/ACLPRClipper Realty14016.15 million7.59 millionOptionableFVRFrontView REITN/A19.09 million18.27 millionN/AOACCOaktree Acquisition Corp. III Life SciencesN/A22.42 millionN/AN/ACLPR, BZAI, FVR, and OACC HeadlinesRecent News About These CompaniesOaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Down 0.1% - What's Next?July 4 at 4:34 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLPR, BZAI, FVR, and OACC Company DescriptionsBlaize NASDAQ:BZAI$2.86 +0.04 (+1.42%) As of 10:33 AM EasternBlaize® has created a transformative new compute solution that unites silicon and software to optimize AI from the edge to the core. We’re partnering with customers to transform their products so they can deliver better experiences and better lives.Clipper Realty NYSE:CLPR$3.72 -0.15 (-3.88%) As of 10:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Clipper Realty Inc. (NYSE: CLPR) is a self-administered and self-managed real estate company that acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn.FrontView REIT NYSE:FVR$12.21 -0.27 (-2.16%) As of 10:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.FrontView REIT specializes in real estate investing.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.41 -0.03 (-0.29%) As of 09:30 AM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Warehouse Wars: Can BJ’s Take Advantage of Costco’s Weakness? Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story CAVA Group: Why the Growth Story Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
